Alex Tzanidis

Davies Collison Cave

Legal Influencer

Q3 | 2018

Legal Influencers

Lexology’s Legal Influencers programme recognises firms and authors that provide excellent content within a work area and region. Find out more

  • Q3 | 2018 in Healthcare and life sciences - Australasia


Results 1 to 5 of 25

Clinical trial disclosures a significant risk to patent validity in Australia

Australia - August 1 2022 We recently published in Australasian Biotechnology (and on our website) on the nexus between IP and clinical trials in Australia, in which we…

Claire Gregg

Focus on Medicinal Cannabis - Malaysia to allow the import and use of medicinal cannabis

Malaysia - November 17 2021 Based on recent reports emerging from Malaysian news outlets, the Malaysian Health Minister, Khairy Jamaluddin, has unexpectedly indicated that…

Sally J Davis

Prior art in the age of COVID

Australia - October 19 2021 Information sharing practices during the COVID-19 era are contributing to a growing bank of prior art and, further, are increasing the risk of…

Dr Lyn Chan

The nexus between IP and clinical trials: An Australian perspective

Australia - October 14 2021 An inherent tension exists at the nexus between IP and clinical trials arising from the requirements for obtaining patent protection and the…

Claire Gregg

Focus on Medicinal Cannabis - South Korea to be the first East Asian Country to Legalise Medicinal Cannabis

South Korea - November 30 2018 In a surprise development this week, the South Korean government passed legislation to permit patient access to medicinal cannabis. Changes to the…

Sally J Davis